TY - JOUR
T1 - Lafora disease ubiquitin ligase malin promotes proteasomal degradation of neuronatin and regulates glycogen synthesis
AU - Sharma, Jaiprakash
AU - Rao, Sudheendra N.R.
AU - Shankar, Susarla Krishna
AU - Satishchandra, Parthasarathy
AU - Jana, Nihar Ranjan
N1 - Funding Information:
This work was supported by the Department of Biotechnology, Government of India . J. S. was supported by research fellowship from Department of Biotechnology, Government of India. We are thankful to Dr. S. Ganesh for providing mutant malin constructs and Dr. Alan R. Saltiel for muscle glycogen synthase construct.
PY - 2011/10
Y1 - 2011/10
N2 - Lafora disease (LD) is the inherited progressive myoclonus epilepsy caused by mutations in either EPM2A gene, encoding the protein phosphatase laforin or the NHLRC1 gene, encoding the ubiquitin ligase malin. Since malin is an ubiquitin ligase and its mutations cause LD, it is hypothesized that improper clearance of its substrates might lead to LD pathogenesis. Here, we demonstrate for the first time that neuronatin is a novel substrate of malin. Malin interacts with neuronatin and enhances its degradation through proteasome. Interestingly, neuronatin is an aggregate prone protein, forms aggresome upon inhibition of cellular proteasome function and malin recruited to those aggresomes. Neuronatin is found to stimulate the glycogen synthesis through the activation of glycogen synthase and malin prevents neuronatin-induced glycogen synthesis. Several LD-associated mutants of malin are ineffective in the degradation of neuronatin and suppression of neuronatin-induced glycogen synthesis. Finally, we demonstrate the increased levels of neuronatin in the skin biopsy sample of LD patients. Overall, our results indicate that malin negatively regulates neuronatin and its loss of function in LD results in increased accumulation of neuronatin, which might be implicated in the formation of Lafora body or other aspect of disease pathogenesis.
AB - Lafora disease (LD) is the inherited progressive myoclonus epilepsy caused by mutations in either EPM2A gene, encoding the protein phosphatase laforin or the NHLRC1 gene, encoding the ubiquitin ligase malin. Since malin is an ubiquitin ligase and its mutations cause LD, it is hypothesized that improper clearance of its substrates might lead to LD pathogenesis. Here, we demonstrate for the first time that neuronatin is a novel substrate of malin. Malin interacts with neuronatin and enhances its degradation through proteasome. Interestingly, neuronatin is an aggregate prone protein, forms aggresome upon inhibition of cellular proteasome function and malin recruited to those aggresomes. Neuronatin is found to stimulate the glycogen synthesis through the activation of glycogen synthase and malin prevents neuronatin-induced glycogen synthesis. Several LD-associated mutants of malin are ineffective in the degradation of neuronatin and suppression of neuronatin-induced glycogen synthesis. Finally, we demonstrate the increased levels of neuronatin in the skin biopsy sample of LD patients. Overall, our results indicate that malin negatively regulates neuronatin and its loss of function in LD results in increased accumulation of neuronatin, which might be implicated in the formation of Lafora body or other aspect of disease pathogenesis.
KW - Glycogen synthesis
KW - Lafora disease
KW - Malin
KW - Neuronatin
KW - Ubiquitin ligase
UR - http://www.scopus.com/inward/record.url?scp=79961127916&partnerID=8YFLogxK
U2 - 10.1016/j.nbd.2011.06.013
DO - 10.1016/j.nbd.2011.06.013
M3 - Article
C2 - 21742036
AN - SCOPUS:79961127916
SN - 0969-9961
VL - 44
SP - 133
EP - 141
JO - Neurobiology of Disease
JF - Neurobiology of Disease
IS - 1
ER -